These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of pretibial myxedema (PTM) with topical steroid ointment application with sealing cover (steroid occlusive dressing technique: steroid ODT) in Graves' patients. Takasu N, Higa H, Kinjou Y. Intern Med; 2010; 49(7):665-9. PubMed ID: 20371956 [Abstract] [Full Text] [Related]
4. [Pretibial myxedema after Graves' disease: A differential diagnosis of lymphedema]. Lebreton O, Seddiki R, Abba S, Vignes S. Rev Med Interne; 2023 Dec; 44(12):641-645. PubMed ID: 37827928 [Abstract] [Full Text] [Related]
5. Is Graves' dermopathy a generalized disorder? Peacey SR, Flemming L, Messenger A, Weetman AP. Thyroid; 1996 Feb; 6(1):41-5. PubMed ID: 8777383 [Abstract] [Full Text] [Related]
6. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema. Arnold K, Metcalfe R, Weetman AP. J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579 [Abstract] [Full Text] [Related]
7. Early onset pretibial myxedema in the absence of ophthalmopathy: a morphologic evolution. Omohundro C, Dijkstra JW, Camisa C, Bergfeld WF. Cutis; 1996 Sep; 58(3):211-4. PubMed ID: 8886536 [Abstract] [Full Text] [Related]
8. Pretibial Myxedema Masquerading as a Venous Leg Ulcer. Herskovitz I, Hughes O, MacQuhae F, Kirsner RS. Wounds; 2017 Mar; 29(3):77-79. PubMed ID: 28355140 [Abstract] [Full Text] [Related]
9. [Pretibial myxedema: pathogenetic features and clinical aspects]. Sabanova EA, Fadeyev VV, Potekaev NN, Lvov AN. Probl Endokrinol (Mosk); 2019 Jun 30; 65(2):134-138. PubMed ID: 31271716 [Abstract] [Full Text] [Related]
10. Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy. Janssen JAMJL, Smith TJ. Cells; 2021 Feb 12; 10(2):. PubMed ID: 33673340 [Abstract] [Full Text] [Related]
11. A case of pretibial myxedema treated with teprotumumab. Petit L, Catinis A, Richard E, Silverberg J. JAAD Case Rep; 2021 Oct 12; 16():134-136. PubMed ID: 34604488 [No Abstract] [Full Text] [Related]
13. Pretibial myxedema with Graves' disease: a case report and review of Japanese literature. Ishizawa T, Sugiki H, Anzai S, Kondo S. J Dermatol; 1998 Apr 12; 25(4):264-8. PubMed ID: 9609987 [Abstract] [Full Text] [Related]
14. Immunoglobulin G of patients with circumscribed pretibial myxedema of Graves' disease stimulates proteoglycan synthesis in human skin fibroblasts in culture. Shishiba Y, Imai Y, Odajima R, Ozawa Y, Shimizu T. Acta Endocrinol (Copenh); 1992 Jul 12; 127(1):44-51. PubMed ID: 1519422 [Abstract] [Full Text] [Related]
15. Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy. Smith TJ. Best Pract Res Clin Endocrinol Metab; 2020 Jan 12; 34(1):101383. PubMed ID: 32088116 [Abstract] [Full Text] [Related]
16. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Daumerie C, Ludgate M, Costagliola S, Many MC. Eur J Endocrinol; 2002 Jan 12; 146(1):35-8. PubMed ID: 11751064 [Abstract] [Full Text] [Related]
17. [A woman with red, swollen lower legs]. Siemerink M, van Praag MC. Ned Tijdschr Geneeskd; 2010 Jan 12; 154():A1186. PubMed ID: 20977783 [Abstract] [Full Text] [Related]